Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The factor VIII complex: structure and function.

L W Hoyer

    Blood
    |July 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Normal human plasma contains two key proteins for blood clotting: factor VIII procoagulant protein and von Willebrand factor. Understanding their distinct roles and genetic control offers insights into hemophilia and von Willebrand diseases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.

    Thrombosis research·2001
    Same author

    Characterization of the immune response to factor VIII using hemophilia A* mice.

    Haematologica·2001
    Same author

    Mechanism of the immune response to human factor VIII in murine hemophilia A.

    Thrombosis and haemostasis·2001
    Same author

    Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer.

    European journal of immunology·2000
    Same author

    Prevention and treatment of factor VIII inhibitors in murine hemophilia A.

    Blood·2000
    Same author

    Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.

    Thrombosis and haemostasis·1999

    Area of Science:

    • Biochemistry
    • Hematology
    • Genetics

    Background:

    • Human plasma contains a complex of two proteins crucial for hemostasis and coagulation.
    • These proteins are the factor VIII procoagulant protein (antihemophilic factor) and the factor VIII-related protein (von Willebrand factor).

    Purpose of the Study:

    • To provide a preliminary understanding of the molecular defects in hemophilia and von Willebrand's diseases.
    • To highlight the distinct genetic control, biochemical properties, and physiologic functions of factor VIII and von Willebrand factor.

    Main Methods:

    • Analysis of existing information on factor VIII and von Willebrand factor.
    • Comparison of their biochemical and immunologic properties.
    • Review of genetic control mechanisms.

    Related Experiment Videos

    Main Results:

    • Factor VIII procoagulant protein and von Willebrand factor are under separate genetic control.
    • These proteins possess distinct biochemical and immunologic properties.
    • Both proteins have unique and essential physiologic functions in hemostasis.

    Conclusions:

    • The distinct nature of factor VIII and von Willebrand factor allows for a preliminary understanding of molecular defects in related diseases.
    • Further research is needed to determine the exact nature of their interaction and biochemical structures.